| Dr Avrum I Froimson, MD | |
|
26900 Cedar Rd, Suite 305 South, Beachwood, OH 44122-1191 | |
| (216) 839-3734 | |
| (216) 839-3727 |
| Full Name | Dr Avrum I Froimson |
|---|---|
| Gender | Male |
| Speciality | Orthopaedic Surgery |
| Location | 26900 Cedar Rd, Beachwood, Ohio |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205891769 | NPI | - | NPPES |
| 0024020 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | 35022540F (Ohio) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Avrum I Froimson, MD 26900 Cedar Rd, Suite 305 South, Beachwood, OH 44122-1191 Ph: (216) 839-3734 | Dr Avrum I Froimson, MD 26900 Cedar Rd, Suite 305 South, Beachwood, OH 44122-1191 Ph: (216) 839-3734 |
News Archive
In the first study using magnetic resonance imaging (MRI) to evaluate cardiovascular risk in World Trade Center (WTC) first responders, researchers from Mount Sinai School of Medicine have found that the responders who experienced high levels of exposure to the initial dust cloud on September 11, 2001, demonstrate high-risk features of atherosclerosis.
Two-thirds of the nation's 1,131 public hospitals were in rural areas in 2008, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.
If the governor and the legislature refuse to accept the federal deal [for Medicaid expansion] -; as 24 states have so far -; they in effect vote against one of the most fantastic cash-flow deals ever offered them. ... And it gets worse.
Research led by the University of Plymouth and Technische Universität Dresden has identified a new therapeutic target for cancer treatment and tissue regeneration - a protein called Prominin-1.
Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.
› Verified 9 days ago
Reuben Gobezie, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 25501 Chagrin Blvd Ste 200, Beachwood, OH 44122 Phone: 844-746-8537 Fax: 216-450-1810 | |
Mrs. Kimberly Lynn Trutza, APRN Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 25501 Chagrin Blvd, Beachwood, OH 44122 Phone: 216-545-4800 | |
Dr. Jinyoung Jeong, M.D.,PH.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 26300 Seville Dr Apt 111, Beachwood, OH 44122 Phone: 216-269-3488 | |
William J Petersilge, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1000 Auburn Dr # 210, Beachwood, OH 44122 Phone: 216-844-5595 Fax: 216-844-5522 |